Toyota Motor sold 10.8 million vehicles globally in 2024, retaining its position as the world's biggest carmaker. The Japanese automakers had announced a plan to combine in December. Novo's Wegovy and ...

Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound doubled in the fourth quarter year over year, despite ...

We expect Lilly to continue to grow faster than the market, and model 60% 2025 Lilly GLP-1 sales growth. Lilly gained 5 points in US prescription share in 2024, and Zepbound’s 56% share of new ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

AdvanCell, an Australia-based radiopharmaceutical company, has raised $112m as investor interest in the radiopharma sector ...

U.S. markets closed mixed with S&P 500 and Nasdaq gaining, while Dow slipped. Economic data exceeded expectations, while commodities and futures showed mixed results. Markets await key reports and ...

The first participants in an international clinical trial aimed at preventing Alzheimer’s disease in young adults at high ...

Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.

As Valentine's Day approaches, the UConn School of Pharmacy wants to celebrate the chemistry we find in and out of our ...

Registered Phase-1b 12-week study investigating safety, diabetes control, and weight loss KELOWNA, BC / ACCESS Newswire / February 5, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "L ...